icon-folder.gif   Conference Reports for NATAP  
 
  18th European AIDS Conference
October 27th-30th, 2021
Online & United Kingdom
Back grey_arrow_rt.gif
 
 
 
Highly Effective Two-drug Regimens of an Integrase Inhibitor and Reverse Transcriptase Inhibitor in Real-World Setting - Data from COMBINE-2 Study
 
 
  EACS 2021 Oct 27-30
 
Cristina Mussini,1 Cassidy Henegar,2 Lambert Assoumou,3 Stephane De Wit,4 Margaret Johnson,5 Eugenia Quiros Roldan,6 Leigh Ragone,2 Jean van Wyk,7 Michael Aboud,7 Carl Fletcher,8 Annie Duffy,8 Anton Pozniak,3 Vani Vannappagari 2 on behalf of the COMBINE-2 Study Group
1University of Modena and Reggio Emilia, Policlinico Hospital, Infectious Diseases Clinic, Modena, Italy; 2ViiV Healthcare, RTP, US; 3 The European treatment network for HIV, hepatitis and global infectious diseases (NEAT-ID), London, UK; 4Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium, 5Royal Free Hospital, London, UK; 6 University of Brescia, Brescia, Italy; 7ViiV Healthcare, Brentford, Middlesex, UK; 8Research Organization (KC) Ltd., London, UK;

1101211

1101212

1101213

1101214

1101215

1101216

1101217